Nanosensor Markets – 2014: Global Industry Analysis, Size, Shares, Growth, Trends and Forecast Research Report …

Posted on by

Albany, NY (PRWEB) February 18, 2014

Nanosensors-devices capable of detecting nanoparticles-are already in use in the medical diagnosis field, but are expected to see near-term commercialization in military, domestic security and environmental monitoring applications, as well as several other areas. NanoMarkets believes that longer-term revenue generation from nanosensors will also emerge from a variety of uses for such sensors in microelectronics manufacturing and in the construction market. In addition, we also believe that the near-term development of nanosensors will be an important enabling technology for the Internet-of-Things" and robotics.

View Full Report With Complete TOC at http://www.researchmoz.us/nanosensor-markets-2014-report.html

This report identifies where and how the commercial opportunities presented by nanosensors will appear and provides detailed projections of the size of these opportunities over the coming eight years. Each nanosensor application is analyzed in detail, showing how it will be brought to market. The report also discusses the strategies being deployed by nanosensor firms and also provides an overview of noteworthy nanosensor commercialization initiatives.

In addition, to being a valuable guide for marketing and product management in the sensor industry, this report will also be required reading for executives in the specialty chemical industry, since it discusses how specific biological and nanomaterials will be used in nanosensors. Coverage of materials includes biological materials and inorganic nanomaterials including graphene and quantum dots. This report also analyzes the business implications notable trends in the fabrication of nanosensors including developments in bottom-up assembly, self-assembly and top-down lithography.

Browse Other Published Reports By NanoMarkets at http://www.researchmoz.us/publisher/nanomarkets-22.html

Related Reports -

Biopreservation Market (Product Types - Equipment, LIMS, and Media; Applications - Regenerative Medicine, Biobanking, and Drug Discovery) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019

This report encompasses market estimations for biopreservation market for the forecast period 2013 to 2019. The market size is forecasted considering 2012 as the base year and is represented in terms of USD million. The report caters to market players in the biopreservation industry who aspire to gain further insights into this market in terms of different product types and application markets.

The global biopreservation market is categorized on the basis of product type, application and geography. The market estimates, from the period 2011 to 2019, for each of these segments is provided in USD million.

View original post here:

Nanosensor Markets - 2014: Global Industry Analysis, Size, Shares, Growth, Trends and Forecast Research Report ...

HealthWatch: Dial a Diagnosis-Cell Phones to the Rescue: Medicine's Next Big Thing?

Posted on by

LOS ANGELES, Cali. (Ivanhoe Newswire) -- Almost seven billion of us use one, and now researchers say that phone you talk, text, and tweet with could one day do much more for your health.

Hannah Gooch is allergic to eggs.

"We did a strict avoidance," Necia Joy Gooch, Hannah's mom, told Ivanhoe.

Spike Loy has diabetes.

"Since I was seven and a half, I had to take between two and 10 blood tests a day," Spike said.

Both could one day benefit from a medical breakthrough that you carry around every day.

"You can imagine your cell phone working like a very advanced microscope for looking at various different specimen," Aydogan Ozcan, PhD, Associate Professor of Electrical Engineering and BioEngineering, UCLA, told Ivanhoe.

Researchers at UCLA created various attachments that fit on smart phones. One can perform an HIV screening. Another ONE detects allergens in food. A special tube measures allergens optically with the phone's camera.

"You can do this for peanuts or you can do this for other kinds of allergens," Dr. Ozcan said.

Other attachments measure the presence of E. coli in food, blood cell counts, and blood sugar levels. Cell phones are less expensive than a large lab and can be used in the field with immediate results.

Originally posted here:

HealthWatch: Dial a Diagnosis-Cell Phones to the Rescue: Medicine's Next Big Thing?

ANM2014 conference proceedings

Posted on by

I am delighted that Materials Today: Proceedings will be able to help share the work presented at ANM 2014.Stewart Bland, Editor, Materials Today

Materials Today is happy to announce that selected proceedings from the forthcoming 5th International Conference on Advanced Nano Materials will be published in Materials Today: Proceedings.

This international event will connect scientists from around the world, to exchange their experience and ideas in cutting edge nanomaterials for future applications, including nano-electronics, nano-mechanics, nano-medicine and nano-energy.

Serving as an interactive platform for researchers from academy and industry, the conference will allow peers to meet and discuss the possibilities of transfer of knowledge, commercialization and funding.

Materials Today: Proceedings is a new journal, launched in 2013, specializing in the publication of conference proceedings.The journal provides the materials science community with a fast and flexible route to the publication of research presented at leading scientific conferences spanning the field of materials science, technology and engineering.

"I am delighted that Materials Today: Proceedings will be able to help share the work presented at ANM 2014", said journal Editor Stewart Bland. "We launched the journal at the end of last year to help showcase and preserve research presented at significant conferences and meetings, and its great to see such a strong start to the publication.

Visit the conference website for more information, coming soon.

More information on Materials Today: Proceedings can be found online, where conference organizers are welcome to submit proposals.

The rest is here:

ANM2014 conference proceedings

Calendar Feb. 17 to Feb.19

Posted on by

Monday

Lecture: The Ethics in Science series will present a talk called Broken Symmetry on the dilemmas of science in post-Cold War, nuclear-age America from 11 a.m. to 12:30 p.m. in Philip Guthrie Hoffman Hall, Room 232.

Lecture: The director of New York Universitys Irish studies program will discuss forms of Irish writing and print culture in the late 18th century from 5 to 7 p.m. in the Honors Commons on the second floor of the M. D. Anderson Memorial Library.

Music: The AURA Contemporary Ensemble will perform works by Leo Brouwer, Lorenzo Ferrero and other composers from 7:30 to 9 p.m. in the Moores Opera House. Student tickets are $7.

Music: Flautist Aralee Dorough will perform works by Claude Debussy, Eugene Bozza and other composers in Feeling So Alone from 7:30 to 9:30 p.m. in the Moores School of Music Choral Recital Hall, Room 160.

Tuesday

Seminar: President and CEO of Buckeye GP Clark C. Smith will share his thoughts in a presentation called Midstream and the Keystone Pipeline from 6 to 7 p.m. in the Cemo Hall Stubblefield Auditorium.

Wednesday

Workshop: Counseling and Psychological Services will continue its Food for Thought series by discussing body images and how to overcome those concerns from noon to 1 p.m. in the Student Services Center 1, Room 210D.

Health: Information about living a balanced, healthy lifestyle will be presented to students along with free food and games from 4 to 6 p.m. at the Campus Recreation and Wellness Center.

More here:

Calendar Feb. 17 to Feb.19

Sports Medicine Experts Say Female Athlete Triad Syndrome a Growing Concern

Posted on by

Contact Information

Available for logged-in reporters only

Newswise When an adolescent female patient comes to Nationwide Childrens Hospitals Sports Medicine clinic, not only are these young women treated for their sports-related injury, but their sports medicine physician will also ask if theyve missed any periods, because of a growing concern among female athletes.

Anastasia Fischer, MD, a physician in Sports Medicine at Nationwide Childrens, says that is because female athlete triad syndrome is more prevalent than previously realized. The female athlete triad has three interrelated components: disordered eating low energy availability (often caused by not eating appropriately), dysmenorrhea (change in a girl's period), and low bone mineral density.

Regan, a high-school track and cross-country athlete from Columbus, Ohio, said she didnt realize how serious the symptoms she was experiencing were until she suffered a stress fracture. The sports medicine team at Nationwide Childrens helped her realize that this injury, and her loss of bone density, was due to the fact that she needed several hundred more calories a day than she realized because of how many she burns as a busy high school athlete.

Many girls are so active they need 3,500 calories a day because they are competing at a high-level, said Dr. Fischer. Some girls who have this syndrome do have serious eating disorders, but most do not. Rather, most adolescents just do not realize how important eating the appropriate amount of calories and proper nutrition is for their athletic performance and general wellbeing. Girls underestimate that food is fuel.

Dr. Fischer, also a faculty member with The Ohio State University College of Medicine, says the triad is a continuum and when it is broken down, you can see how the three elements are interrelated and that many girls fall along this scale. She suggests this might not just be an athlete problem, but an adolescent American problem. New research is even showing that early hormonal detection could help these adolescent females even before they start missing periods, when they could first be at risk for problems the female athlete triad.

It may be uncomfortable for a young female athlete to let her coach, or even her parent, know that she is missing periods, said Dr. Fischer, so she is currently researching how school physicals, required to play school sports in the state of Ohio, could help address this problem early on.

Jessica Buschmann, RD, a dietitian in Sports Medicine at Nationwide Childrens, consults with female athlete triad patients like Regan when they are first diagnosed. She sees not only female athletes who suffer from the female athlete triad who benefit in their sport from being lean, like rowing and track, but also patients in aesthetic sports where athletes are partly judged by their appearance, wear more revealing attire, or may be judged, like gymnastics and dance.

Buschmanns advice to the female adolescents she works with is that they should be tracking their menstrual cycle, which can now be done easily and privately using an app for their smartphone. Girls should talk to their parent or doctor if they are going more than 35 days in between periods, skipping occasional periods, if their periods have stopped, or if they are 15 years old and have not yet experienced a menstrual cycle. By eating meals with their children, parents can assess their attitudes about eating. All athletes should have a nutrition plan that consists of getting enough calories throughout the day.

Follow this link:

Sports Medicine Experts Say Female Athlete Triad Syndrome a Growing Concern

Annals of Internal Medicine tip sheet for Feb. 18, 2014

Posted on by

PUBLIC RELEASE DATE:

17-Feb-2014

Contact: Megan Hanks mhanks@acponline.org 215-351-2656 American College of Physicians

1. Aortic valve replacement improves function but may not improve quality of life

Transcatheter aortic valve replacement (TAVR) improves functional status but may not improve overall quality of life, according to an article being published in Annals of Internal Medicine. Aortic stenosis (AS) is the most common valvular heart disease in developing countries and it affects up to 3 percent of adults older than 75. In recent years, TAVR has emerged as an alternative treatment to surgical aortic valve replacement (SAVR) for high-risk or inoperable patients with symptomatic severe AS. Researchers reviewed 62 published studies to evaluate the changes in functional status and quality of life after TAVR. The research suggested that TAVR improved symptoms, physical function, and disease-specific measures of quality of life compared with conservative treatment. However, the benefits in psychological dimension and general health measures were often small and inconsistent, which may be an important consideration for older patients looking to improve quality of remaining life.

Note: The URL will go live at 5:00 p.m. on Monday, February 17 and can be included in news stories. For an embargoed PDF, please contact Megan Hanks or Angela Collom. To interview an author, please contact Kelly Lawman at klawman@bidmc.harvard.edu or 617-667-7305.

2. Rituximab may not benefit patients with primary Sjgren syndrome

Rituximab appears to offer no long term benefit to patients with primary Sjgren syndrome (pSS), according to an article published in Annals of Internal Medicine. pSS is a chronic autoimmune disorder characterized by dryness of the eyes and mouth. Up to half of patients have systemic involvement, with fatigue being a symptom associated with significant disability. No systemic treatment has been proved to significantly improve symptoms. Mounting evidence on B cell involvement in pSS suggests that B-cell depletion could be an effective treatment for pSS. The CD20 antigen, a transmembrane protein found on pre-B and mature B cells, is the most widely studied target for achieving B-cell depletion. Rituximab is an anti-CD20 antibody. Researchers conducted a multicenter, double-blind, placebo-controlled, randomized trial to evaluate the efficacy and harms of rituximab in adults with recent-onset or systemic pSS. They found that rituximab given in two infusions over two weeks alleviated some symptoms, particularly fatigue, early in the trial but did not alleviate symptoms or disease activity at 24 months. More infusion reactions occurred with rituximab than placebo. The data do not support use of rituximab for treating pSS.

Note: The URL will go live at 5:00 p.m. on Monday, February 17 and can be included in news stories. For an embargoed PDF, please contact Megan Hanks or Angela Collom. Dr. Alain Saraux can be contacted directly at alain.saraux@chu-brest.fr.

3. Microsporidiosis a possible cause of infection in transplant patients

See more here:

Annals of Internal Medicine tip sheet for Feb. 18, 2014